J
Jianda Yuan
Researcher at Merck & Co.
Publications - 111
Citations - 21847
Jianda Yuan is an academic researcher from Merck & Co.. The author has contributed to research in topics: Ipilimumab & T cell. The author has an hindex of 43, co-authored 105 publications receiving 18691 citations. Previous affiliations of Jianda Yuan include Kettering University & Cornell University.
Papers
More filters
Journal ArticleDOI
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi,Naiyer A. Rizvi,Matthew D. Hellmann,Matthew D. Hellmann,Alexandra Snyder,Alexandra Snyder,Pia Kvistborg,Vladimir Makarov,Jonathan J. Havel,William Lee,Jianda Yuan,Phillip Wong,Teresa S. Ho,Martin L. Miller,Natasha Rekhtman,Andre L. Moreira,Fawzia Ibrahim,Cameron Bruggeman,Billel Gasmi,Roberta Zappasodi,Yuka Maeda,Chris Sander,Edward B. Garon,Taha Merghoub,Jedd D. Wolchok,Jedd D. Wolchok,Ton N. Schumacher,Timothy A. Chan,Timothy A. Chan +28 more
TL;DR: Treatment efficacy was associated with a higher number of mutations in the tumors, and a tumor-specific T cell response paralleled tumor regression in one patient, suggesting that the genomic landscape of lung cancers shapes response to anti–PD-1 therapy.
Journal ArticleDOI
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder,Vladimir Makarov,Taha Merghoub,Jianda Yuan,Jesse M. Zaretsky,Alexis Desrichard,Logan A. Walsh,Michael A. Postow,Phillip Wong,Teresa S. Ho,Travis J. Hollmann,Cameron Bruggeman,Kasthuri Kannan,Yanyun Li,Ceyhan Elipenahli,Cailian Liu,Christopher T. Harbison,Lisu Wang,Antoni Ribas,Jedd D. Wolchok,Jedd D. Wolchok,Timothy A. Chan +21 more
TL;DR: In this paper, the authors provide clarification and correction to their article "Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma" (Dec. 4, 2014, issue).
Journal ArticleDOI
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Héctor Peinado,Maša Alečković,Simon Lavotshkin,Irina Matei,Bruno Costa-Silva,Gema Moreno-Bueno,Marta Hergueta-Redondo,Caitlin Williams,Guillermo García-Santos,Cyrus M. Ghajar,Ayuko Nitadori-Hoshino,Caitlin Hoffman,Karen Badal,Benjamin A. Garcia,Margaret K. Callahan,Jianda Yuan,Vilma R. Martins,Johan Skog,Rosandra N. Kaplan,Mary S. Brady,Jedd D. Wolchok,Jedd D. Wolchok,Paul B. Chapman,Paul B. Chapman,Yibin Kang,Yibin Kang,Jacqueline Bromberg,Jacqueline Bromberg,David Lyden +28 more
TL;DR: The data show that exosome production, transfer and education of bone marrow cells supports tumor growth and metastasis, has prognostic value and offers promise for new therapeutic directions in the metastatic process.
Journal ArticleDOI
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow,Margaret K. Callahan,Margaret K. Callahan,Christopher A. Barker,Christopher A. Barker,Yoshiya Yamada,Yoshiya Yamada,Jianda Yuan,Shigehisa Kitano,Zhenyu Mu,Teresa S. Rasalan,Matthew Adamow,Erika Ritter,Christine Sedrak,Achim A. Jungbluth,Ramon Chua,Arvin Yang,Ruth Ann Roman,Samuel Rosner,Brenna Benson,James P. Allison,Alexander M. Lesokhin,Alexander M. Lesokhin,Sacha Gnjatic,Jedd D. Wolchok,Jedd D. Wolchok,Jedd D. Wolchok +26 more
TL;DR: A case of the abscopal effect is reported in a patient with melanoma treated with ipilimumab and radiotherapy, with temporal associations of tumor shrinkage with antibody responses to the cancer-testis antigen NY-ESO-1, changes in peripheral-blood immune cells, and increases in antibodies to other antigens after radiotherapy.
Journal ArticleDOI
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
Vinod P. Balachandran,Michael J Cavnar,Shan Zeng,Zubin M. Bamboat,Lee M. Ocuin,Hebroon Obaid,Eric C. Sorenson,Rachel Popow,Charlotte E. Ariyan,Ferdinand Rossi,Peter Besmer,Tianhua Guo,Cristina R. Antonescu,Takahiro Taguchi,Jianda Yuan,Jedd D. Wolchok,James P. Allison,Ronald P. DeMatteo +17 more
TL;DR: It is found that the immune system contributes substantially to the antitumor effects of imatinib in GIST, and concomitant immunotherapy may further improve outcomes in human cancers treated with targeted agents.